Base Royalties. Animas agrees to pay Debiotech a royalty equal to a percentage of Net Revenue of Debiotech Micro-Needle Products sold or placed to end-users by Animas Group. The royalty rate shall be in accordance with Exhibit B.
Appears in 2 contracts
Sources: Micro Needle License, Joint Development and Manufacturing Assistance Agreement, Micro Needle License, Joint Development, and Manufacturing Assistance Agreement (Animas Corp)